Carmat gets approval to resume artificial heart implants trial
Artificial heart maker Carmat has obtained approval from France’s national drugs agency (ANSM) to resume heart implant trials, the company said on Tuesday.
Go to Source
Artificial heart maker Carmat has obtained approval from France’s national drugs agency (ANSM) to resume heart implant trials, the company said on Tuesday.
Go to Source